Higher Age (≥60 Years) Increases the Risk for Adverse Events during Autologous Hematopoietic Stem Cell Transplantation

SIMPLE SUMMARY: Autologous hematopoietic stem cell transplantation (autoHSCT) is a highly regulated procedure for the treatment of various diseases. In a retrospective, observational study from adult patients treated with autoHSCT during the years 2016–2019, we evaluated the occurrence and severity...

Descripción completa

Detalles Bibliográficos
Autores principales: Haubitz, Monika, von Petersdorff, Vittoria S., Helsen, Ingrid, Brunold, Claudio, Oppliger Leibundgut, Elisabeth, Baerlocher, Gabriela M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000699/
https://www.ncbi.nlm.nih.gov/pubmed/36900376
http://dx.doi.org/10.3390/cancers15051584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000699/
https://www.ncbi.nlm.nih.gov/pubmed/36900376
http://dx.doi.org/10.3390/cancers15051584

Ejemplares similares